个人简历

1999年广州中医药大学获博士学位；2001年浙江大学博士后工作站出站。2001年就职于浙江大学药学院，曾在加拿大滑铁卢大学访问学者、多伦多大学项目交流，2003年至今于暨南大学药学院任职。

研究领域

中药制剂新工艺及新产品开发、中药有效成分逆转肿瘤多药耐药作用机制研究。

近期论文

1. Cai, T. and Y. Cai. Triterpenes from the Fungus Poria cocos and Their Inhibitory Activity on Nitric Oxide Production in Mouse Macrophages via blockade of Activating Protein-1 Pathway. Chemistry & Biodiversity, 2011.
2. Cai, T. and Y. Cai. cis-Ampelopsin E, a Stilbene Isolated from the Seeds of Paeoniasuffruticosa, Inhibits Lipopolysaccharide-Stimulated Nitric OxideProduction in RAW 264.7 Macrophages via Blockade of Nuclear Factor-Kappa B Signaling Pathway. Biol. Pharm. Bull. 2011, 34 (9): 1501-1507.
3. Cai, Y., et al. Zhen-wu-tang, a blended traditional Chinese herbal medicine, ameliorates proteinuria and renal damage of streptozotocin-induced diabetic nephropathy in rats. Journal of Ethnopharmacology. 2010, 131 (1): 88-94.
4. Cai, Y., et al. Two New Aristolochic Acid Derivatives from the Roots of Aristolochia fangchi and Their Cytotoxicities. Chem. Pharm. Bull. 2010，58 (8): 1093-1095.
5. Cai, Y., et al. Simultaneous Determination of Eight PDE-5IS Potentially Adult Erated in Herbal Dietary Supplements with TCL and HPLC-PDA-MS Methods. Journal of Liquid Chromatography & Related Technologies, 2010, 33: 1287-1306.
6. Lu J. Z., Wei F., Cai, Y. 2012.A new aristolactarn-type alkaloid from the roots of Aristolochia fangchi. Journal of Asian Natural Products Research, 2102,3 (14):276-280.
7. Cai, Y. The Current Oncology Scholar’s Forum and Workshop. Current Oncology. 2013, 2 (20).